Mitchell Sinkler & Starr’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.45M Buy
42,391
+94
+0.2% +$11K 2.27% 9
2026
Q1
$5.09M Hold
42,297
2.35% 10
2025
Q4
$4.45M Sell
42,297
-2,480
-6% -$233K 2.01% 10
2025
Q3
$3.76M Sell
44,777
-31
-0.1% -$2.55K 1.69% 11
2025
Q2
$3.55M Sell
44,808
-55,625
-55% -$4.42M 1.7% 11
2025
Q1
$9.01M Buy
100,433
+12,891
+15% +$1.2M 2.52% 10
2024
Q4
$8.71M Sell
87,542
-23,268
-21% -$2.4M 2.32% 12
2024
Q3
$11.3M Buy
110,810
+8,521
+8% +$1.01M 2.84% 6
2024
Q2
$12.7M Sell
102,289
-5,217
-5% -$672K 3.26% 4
2024
Q1
$14.2M Sell
107,506
-100,701
-48% -$12.4M 3.55% 4
2023
Q4
$22.7M Buy
208,207
+65,389
+46% +$6.79M 4.13% 3
2023
Q3
$14.7M Buy
142,818
+38,369
+37% +$4.14M 4.52% 4
2023
Q2
$12.1M Sell
104,449
-200
-0.2% -$22.7K 3.42% 7
2023
Q1
$11.1M Buy
104,649
+14,217
+16% +$1.53M 3.29% 9
2022
Q4
$10M Buy
90,432
+8,124
+10% +$830K 3.23% 9
2022
Q3
$7.09M Buy
82,308
+1,557
+2% +$139K 2.75% 11
2022
Q2
$7.36M Buy
80,751
+750
+0.9% +$66.5K 2.7% 12
2022
Q1
$6.56M Sell
80,001
-6,940
-8% -$547K 2.06% 16
2021
Q4
$6.66M Buy
86,941
+64,896
+294% +$5.17M 1.98% 16
2021
Q3
$1.66M Sell
22,045
-370
-2% -$28.1K 1.5% 23
2021
Q2
$1.74M Sell
22,415
-1,495
-6% -$111K 1.59% 20
2021
Q1
$1.76M Buy
23,910
+629
+3% +$46.4K 1.71% 15
2020
Q4
$1.82M Sell
23,281
-2,557
-10% -$196K 1.73% 18
2020
Q3
$2.04M Hold
25,838
2.08% 13
2020
Q2
$1.91M Hold
25,838
2.16% 12
2020
Q1
$1.9M Hold
25,838
2.48% 10
2019
Q4
$2.24M Sell
25,838
-2,212
-8% -$182K 2.38% 7
2019
Q3
$2.25M Sell
28,050
-1,852
-6% -$148K 2.89% 4
2019
Q2
$2.39M Sell
29,902
-183
-0.6% -$14K 2.73% 6
2019
Q1
$2.39M Sell
30,085
-1,708
-5% -$128K 2.76% 4
2018
Q4
$2.32M Sell
31,793
-3,464
-10% -$245K 2.86% 5
2018
Q3
$2.39M Sell
35,257
-964
-3% -$61.4K 2.5% 7
2018
Q2
$2.1M Sell
36,221
-603
-2% -$34K 2.31% 10
2018
Q1
$1.91M Buy
36,824
+15,348
+71% +$829K 2.18% 15
2017
Q4
$1.15M Hold
21,476
1.71% 21
2017
Q3
$1.31M Buy
21,476
+315
+1% +$19.1K 2.06% 14
2017
Q2
$1.29M Sell
21,161
-1,410
-6% -$85.8K 2.12% 13
2017
Q1
$1.37M Sell
22,571
-4,192
-16% -$254K 2.22% 14
2016
Q4
$1.5M Sell
26,763
-838
-3% -$49K 2.11% 14
2016
Q3
$1.64M Hold
27,601
2.58% 10
2016
Q2
$1.52M Sell
27,601
-629
-2% -$33.5K 2.07% 14
2016
Q1
$1.43M Hold
28,230
1.97% 17
2015
Q4
$1.42M Sell
28,230
-4,192
-13% -$211K 1.94% 17
2015
Q3
$1.53M Hold
32,422
1.97% 17
2015
Q2
$1.76M Buy
32,422
+183
+0.6% +$10.3K 2.08% 16
2015
Q1
$1.77M Hold
32,239
1.99% 17
2014
Q4
$1.75M Hold
32,239
1.95% 21
2014
Q3
$1.82M Buy
32,239
+289
+0.9% +$16.2K 2.04% 15
2014
Q2
$1.76M Hold
31,950
1.9% 19
2014
Q1
$1.73M Sell
31,950
-367
-1% -$19K 1.94% 16
2013
Q4
$1.54M Sell
32,317
-2,777
-8% -$127K 1.73% 22
2013
Q3
$1.59M Sell
35,094
-487,400
-93% -$22.3M 1.83% 21
2013
Q2
$23.2M Buy
+522,494
New +$23.3M 5.08% 3

Other funds holding MRK

Mitchell Sinkler & Starr's MRK Position: Q2 2026 in Review

Mitchell Sinkler & Starr increased its Merck (MRK) stake by 0.22% in Q2 2026, buying an estimated $11K and bringing the position to 42,391 shares worth $5.45M. The position accounts for 2.27% of the portfolio, ranked #9.

Mitchell Sinkler & Starr first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.2M in Q2 2013. 1,245 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Mitchell Sinkler & Starr held 42,391 shares of Merck worth $5.45M as of Q2 2026.
  • Mitchell Sinkler & Starr bought 94 Merck shares in Q2 2026, an estimated $11K.
  • Merck made up 2.27% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #9 holding.
  • Mitchell Sinkler & Starr first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Mitchell Sinkler & Starr's Merck position peaked at $23.2M in Q2 2013.
  • 1,245 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.